Proceedings of the 1st International Conference for Health Research – BRIN (ICHR 2022)

Comparison of the Variation Cost of COVID-19 Medicine Among Public and Private Hospitals in Indonesia

Authors
Wahyu P. Nugraheni1, *, Hasbullah Thabrany2
1Research Centre of Public Health and Nutrition, National Research and Innovation Agency, Jakarta, Indonesia
2Thinkwell Global, Jakarta, Indonesia
*Corresponding author. Email: nugraheni_wp@yahoo.com
Corresponding Author
Wahyu P. Nugraheni
Available Online 1 March 2023.
DOI
10.2991/978-94-6463-112-8_54How to use a DOI?
Keywords
medicine cost of COVID-19; public and private hospitals; Indonesia
Abstract

Cost information is important for efficiently allocating healthcare expenditures, estimating future budget allocation, and setting user fees to start new financing systems. Indonesia has a very high number of COVID-19 cases. Because of new instances, Indonesia requires information on the cost of COVID services, one of which is information on the cost of COVID-19 treatment medicine. This study assesses the cost of medical services for COVID-19 patients in public and private hospitals based on the severity from the provider’s perspective. This study also analyses variations in the price of COVID-19 treatment medicine based on the type and class of hospital to allocate and manage the budget appropriately. A hospital-based cross-sectional study was conducted in 9 public and 7 private hospitals spread across 5 provinces in Indonesia for the financial year 2020. The activity-based costing method was applied to calculate the unit cost of the cost of drugs for inpatient covid-19 treatment per episode of disease according to severity. Costs are calculated using Microsoft Excel 2010. The differentiating factor for patient care in hospitals for COVID-19 patients is the severity level. The average cost of medicine for COVID-19 patients with mild symptoms in government hospitals is IDR. 734,305.5, moderate symptoms IDR 1,685,200.25, severe symptoms IDR 6,126,585.6 and with critical condition IDR 3,035,938.3. The average variation in the cost of medicine for treating COVID-19 patients in private hospitals is high in each hospital class for the same severity of illness. The average cost of COVID -19 treatment drugs for patients with mild symptoms is IDR 1,782,489, moderate symptoms IDR. 2,527,738.6, severe symptoms of IDR. 2,229,679.5 and in critical condition IDR. 15,331,045.5. The cost of COVID-19 treatment drugs is influenced by the flow of COVID-19 treatment, length of stay, type of hospital, hospital class, and severity of illness. There is a wide variation in the average cost of medicine for treating COVID-19 patients in hospitals, both styles, and types of hospitals at the same severity level. The average treatment price for COVID-19 patients in private hospitals is more expensive than in government hospitals for mild, moderate, and critical conditions. However, the average cost of medicine for COVID-19 patients with severe symptoms is more costly at government hospitals compared to private hospitals.

Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

Volume Title
Proceedings of the 1st International Conference for Health Research – BRIN (ICHR 2022)
Series
Advances in Health Sciences Research
Publication Date
1 March 2023
ISBN
978-94-6463-112-8
ISSN
2468-5739
DOI
10.2991/978-94-6463-112-8_54How to use a DOI?
Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

TY  - CONF
AU  - Wahyu P. Nugraheni
AU  - Hasbullah Thabrany
PY  - 2023
DA  - 2023/03/01
TI  - Comparison of the Variation Cost of COVID-19 Medicine Among Public and Private Hospitals in Indonesia
BT  - Proceedings of the 1st International Conference for Health Research – BRIN (ICHR 2022)
PB  - Atlantis Press
SP  - 591
EP  - 598
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-112-8_54
DO  - 10.2991/978-94-6463-112-8_54
ID  - Nugraheni2023
ER  -